Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules

Journal of Immunology

Volumn 162, Issue 3, 1999, Pages 1502-1509

  Thayer, Wesley P ^a   Ignatowicz, Leszek ^b   Weber, Dominique A ^a   Jensen, Peter E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; COMPLEX FORMATION; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STABILITY; PROTEIN TRANSPORT;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; BASE SEQUENCE; BINDING SITES; BIOLOGICAL TRANSPORT, ACTIVE; COS CELLS; DNA PRIMERS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR1 ANTIGEN; HUMANS; MICE; MUTATION; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECOMBINANT PROTEINS; SOLUBILITY;

EID: 0033082484     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Ceman, S., and A. J. Sant. 1995. The function of invariant chain in class II-restricted antigen presentation. Semin Immunol 7:373.
2. Pieters, I. 1997. MHC class II restricted antigen presentation. Curr. Opin. Immunol. 9:89.
3. Jensen, P. E. 1997. Peptide binding and antigen presentation by class II histocompatibility glycoproteins. Biopolymers 43:303.
4. Machamer, C. E., and P. Cresswell. 1982. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens. J. Immunol. 129:2564.
5. Kvist, S., K. Wilman, L. Claesson, P. A. Peterson, and B. Dobberstein. 1982. Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens. Cell 29:61.
6. Roche, P. A., M. S. Marks, and P. Cresswell. 1991. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 354:392.
7. Blum, J. S., and P. Cresswell. 1988. Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc. Natl. Acad. Sci. USA 85:3975.
8. i to p25. J. Immunol. 140:2670.
9. Maric, M. A., M. D. Taylor, and J. S. Blum. 1994. Endosomal aspartic proteinases are required for invariant-chain processing. Proc. Natl. Acad. Sci. USA 91:2171.
10. Riese, R. J., P. R. Wolf, D. Bromme, L. R. Natkin, J. A. Villadandos, H. L. Ploegh, and H. A. Chapman. 1996. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 4:357.
11. Ghosh, P., M. Amaya, E. Mellins, and D. C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 178:457.
12. Sherman, M. A., D. A. Weber, and P. E. Jensen. 1995. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3:197.
13. Sloan, V. S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D. M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375:802.
14. Denzin, L. K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82:155.
15. Anderson, M. S., and J. Miller. 1992. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 89:2282.
16. Layet, C., and R. N. Germain. 1991. Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II major histocompatibility complex AαAβ dimers from the endoplasmic reticulum/cis-Golgi compartment. Proc. Natl. Acad. Sci. USA 88:2346.
17. Viville, S., J. Neefjes, V. Lotteau, A. Dierich, M. LeMeur, H. Ploegh, C. Benoist, and D. Mathis. 1993. Mice lacking the MHC class II-associated invariant chain. Cell 72:635.
18. + T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177:1699.
19. Elliott, E. A., J. R. Drake, S. Amigorena, J. Elsemore, P. Webster, I. Mellman, and R. A. Flavell. 1994. The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J. Exp. Med. 179:681.
20. Bikoff, E. K., R. N. Germain, and E. J. Robertson. 1995. Allelic differences affecting invariant chain dependency of MHC class II subunit assembly. Immunity 2:301.
21. Bakke, O., and B. Dobberstein. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63:707.
22. Loss, G. E., Jr., and A. J. Sant. 1993. Invariant chain retains MHC class II molecules in the endocytic pathway. J. Immunol. 150:3187.
23. Roche, P. A., and P. Cresswell. 1990. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345:615.
24. Teyton, L., D. O'Sullivan, P. W. Dickson, V. Lotteau, A. Sette, P. Fink, and P. A. Peterson. 1990. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature 348:39.
25. Busch, R., I. Cloutier, R. P. Sekaly, and G. J. Hammerling. 1996. Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J. 15:418.
26. Peterson, M., and J. Miller. 1990. Invariant chain influences the immunological recognition of MHC class II molecules. Nature 345:172.
27. Peterson, M., and J. Miller. 1992. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Nature 357:596.
28. Bodmer, H., S. Viville, C. Benoist, and D. Mathis. 1994. Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain. Science 263:1284.
29. Momburg, F., S. Fuchs, J. Drexler, R. Busch, M. Post, G. J. Hammerling, and L. Adorini. 1993. Epitope-specific enhancement of antigen presentation by invariant chain. J. Exp. Med. 178:1453.
30. Busch, R., I. Y. Vturina, J. Drexler, F. Momburg, and G. J. Hammerling. 1995. Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peplides in the absence of invariant chain. Eur. J. Immunol. 25:48.
31. Stumptner, P., and P. Benaroch. 1997 Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region. EMBO J. 16:5807.
32. Germain, R. N., and L. R. Hendrix. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134.
33. Stern, L. J., and D. C. Wiley. 1992. The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide. Cell 68:465.
34. Germain, R. N., and A. G. Rinker, Jr. 1993. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules. Nature 363:725.
35. Sadegh-Nasseri, S., L. J. Stem, D. C. Wiley, and R. N. Germain. 1994. MHC class H function preserved by low-affinity peptide interactions preceding stable binding. Nature 370:647.
36. Reich, Z., J. D. Altman, J. J. Boniface, D. S. Lyons, H. Kozono, G. Ogg, C. Morgan, and M. M. Davis. 1997. Stability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal pH: comparison to class I proteins. Proc. Natl. Acad. Sci. USA 94:2495.
37. Zhong, G., F. Castellino, P. Romagnoli, and R. N. Germain. 1996. Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP). J. Exp. Med. 184:2061.
38. Sette, A., S. Southwood, J. Miller, and E. Appella. 1995. Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J. Exp. Med. 181:677.
39. Liang, M. N., C. Beeson, K. Mason, and H. M. McConnell. 1995. Kinetics of the reactions between the invariant chain (85-99) peptide and proteins of the murine class II MHC. Int. Immunol. 7:1397.
40. Ignatowicz, L., G. Winslow, J. Bill, J. Kappler, and P. Marrack. 1995. Cell surface expression of class II MHC proteins bound by a single peptide. J. Immunol. 154:3852.
41. Cullen, B. R. 1987. Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol. 152:684.
42. Sherman, M. A., H. A. Runnels, J. C. Moore, L. J. Stem, and P. E. Jensen. 1994. Membrane interactions influence the peptide binding behavior of DR1. J. Exp. Med. 179:229.
43. Lampson, L. A., and R. Levy. 1980. Two populations of Ia-like molecules on a human cell line. J. Immunol. 125:293.
44. Shaw, S., A. Zeigler, and R. DeMars. 1985. Specificity of monoclonal antibodies directed against human and murine class II histocompatibility antigens as analyzed by binding to HLA-deletion mutant cell lines. Hum. Immunol. 12:191.
45. Murphy, D., D. Lo, S. Rath, R. Brinster, R. Flavell, A. Slanetz, and C. Janeway. 1989. A novel MHC class II epitope expressed in thymic medulla but not cortex. Nature 338:765.
46. Lipp, J., and B. Dobberstein. 1986. Signal recognition particle-dependent membrane insertion of mouse invariant chain: a membrane-spanning protein with a cytoplasmically exposed amino terminus. J. Cell Biol. 102:2169.
47. Weber, D. A., B. D. Evavold, and P. E. Jensen. 1996. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274:618.
48. Jensen, P. E. 1991. Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH. J. Exp. Med. 174:1111.
49. Tompkins, S. M., P. A. Rota, J. C. Moore, and P. E. Jensen. 1993. A europium fluoroimmunoassay for measuring binding of antigen to class II MHC glycoproteins. J. Immunol. Methods 163:209.
50. Stern, L. J., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215.
51. Bijlmakers, M. J., P. Benaroch, and H. L. Ploegh. 1994. Mapping functional regions in the lumenal domain of the class II-associated invariant chain. J. Exp. Med. 180:623.
52. Romagnoli, P., and R. N. Germain. 1994. The CUP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J. Exp. Med. 180:1107.
53. Park, S. J., S. Sadegh-Nasseri, and D. C. Wiley. 1995. Invariant chain made in Escherichia coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal segment that binds empty HLA-DR1. Proc. Natl. Acad. Sci. USA 92:11289.
54. Rudensky, A. Y., S. Rath, P. Preston-Hurlburt, D. B. Murphy, and C. A. Janeway, Jr. 1991. On the complexity of self. Nature 353:660.
55. Freisewinkel, I. M., K. Schenck, and N. Koch. 1993. The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc. Natl. Acad. Sci. USA 90:9703.
56. Newcomb, J. R., C. Carboy-Newcomb, and P. Cresswell. 1996. Trimeric interactions of the invariant chain and its association with major histocompatibility complex class II αβ dimers. J. Biol. Chem. 271:24249.
57. Kropshofer, H., A. B. Vogt, and G. J. Hammerling. 1995. Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding. Proc. Natl. Acad. Sci. USA 92:8313.
58. Kropshofer, H., A. B. Vogt, L. J. Stern, and G. J. Hammerling. 1995. Self-release of CLIP in peptide loading of HLA-DR molecules. Science 270:1357.
59. Siebenkotten, I. M., C. Carstens, and N. Koch. 1998. Identification of a sequence that mediates promiscuous binding of invariant chain to MHC class II allotypes. J. Immunol. 160:3355.
60. Sanderson, F., C. Thomas, J. Neefjes, and J. Trowsdale. 1996. Association between HLA-DM and HLA-DR in vivo. Immunity 4:87.
61. Stebbins, C. C., M. E. Peterson, W. M. Sun, and A. J. Sant. 1996. DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules. J. Immunol. 157:4892.
62. Denzin, L. K., C. Hammond, and P. Cresswell. 1996. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 184:2153.